Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Geisinger Clinic, |
RCV002285541 | SCV002562120 | pathogenic | Maturity-onset diabetes of the young type 3 | 2022-08-02 | criteria provided, single submitter | research | PVS1, PM2, PP4 |
Ambry Genetics | RCV002373066 | SCV002691999 | pathogenic | Maturity onset diabetes mellitus in young | 2021-01-14 | criteria provided, single submitter | clinical testing | The p.W327* pathogenic mutation (also known as c.981G>A), located in coding exon 8 of the HNF4A gene, results from a G to A substitution at nucleotide position 981. This changes the amino acid from a tryptophan to a stop codon within coding exon 8. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |